Novo Nordisk sales share by therapy area 2021-2022

In both 2021 and 2022, Danish drug manufacturer Novo Nordisk generated four fifths of its total sales in the diabetes care segment. The obesity care segment was significantly smaller, generating nine percent of the company’s total sales, but saw the highest increase between those two years.

…. more: Statista.com (Quelle/Source)